Expression/NN
of/IN
Egr-1/NN
correlates/VBZ
with/IN
the/DT
transformed/VBN
phenotype/NN
and/CC
the/DT
type/NN
of/IN
viral/JJ
latency/NN
in/IN
EBV/NN
genome/NN
positive/JJ
lymphoid/JJ
cell/NN
lines/NNS
./.

In/IN
this/DT
paper/NN
we/PRP
have/VBP
investigated/VBN
the/DT
role/NN
of/IN
Egr-1/NN
in/IN
B/NN
cell/NN
growth/NN
regulation/NN
by/IN
examining/VBG
the/DT
gene/NN
expression/NN
in/IN
a/DT
panel/NN
of/IN
B/NN
cell/NN
lines/NNS
,/,
including/VBG
both/CC
EBV/NN
genome/NN
negative/JJ
and/CC
EBV/NN
carrying/VBG
cell/NN
lines/NNS
./.
=====
Egr-1/NN
expression/NN
correlates/VBZ
with/IN
the/DT
cellular/JJ
phenotype/NN
and/CC
the/DT
specific/JJ
pattern/NN
of/IN
viral/JJ
latency/NN
established/VBN
within/IN
the/DT
individual/JJ
cell/NN
lines/NNS
./.
=====
Thus/RB
,/,
constitutive/JJ
activation/NN
of/IN
Egr-1/NN
gene/NN
is/VBZ
invariably/RB
associated/VBN
with/IN
unrestricted/JJ
expression/NN
of/IN
viral/JJ
latent/JJ
genes/NNS
in/IN
all/DT
group/NN
III/CD
EBV/NN
genome/NN
carrying/VBG
cell/NN
lines/NNS
./.
=====
In/IN
contrast/NN
,/,
Egr-1/NN
expression/NN
is/VBZ
abrogated/VBN
in/IN
group/NN
I/NN
Burkitt/NN
tumor/NN
cells/NNS
,/,
irrespective/JJ
of/IN
the/DT
EBV/NN
genome/NN
carrying/NN
status/NN
./.
=====
Activated/VBN
viral/JJ
gene/NN
expression/NN
associated/VBN
with/IN
phenotypic/JJ
conversion/NN
of/IN
group/NN
I/NN
cell/NN
lines/NNS
in/IN
to/TO
group/NN
II/CD
or/CC
III/CD
restores/VBZ
the/DT
Egr-1/NN
gene/NN
expression/NN
./.
=====
Several/JJ
forms/NNS
of/IN
EGR-1/JJ
protein/NN
are/VBP
found/VBN
within/IN
the/DT
different/JJ
groups/NNS
of/IN
cell/NN
lines/NNS
,/,
and/CC
the/DT
binding/NN
activity/NN
to/TO
DNA/NN
consensus/NN
sequences/NNS
was/VBD
investigated/VBN
./.
=====
Finally/RB
,/,
time/NN
course/NN
analysis/NN
of/IN
Egr-1/NN
expression/NN
during/IN
the/DT
early/JJ
steps/NNS
of/IN
EBV/NN
infection/NN
in/FW
vitro/FW
demonstrated/VBD
that/IN
Egr-1/NN
is/VBZ
upregulated/VBN
within/IN
minutes/NNS
from/IN
the/DT
initial/JJ
interaction/NN
with/IN
the/DT
B/NN
lymphocyte/NN
./.